Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation

Figure 7 Correlation analysis between symptom improvement and individual variability as well as serum levels of brain-derived neurotrophic factor, dopamine, and serotonin. A: Correlation between individual variability and positive and negative syndrome scale (PANSS)/scale for the assessment of negative symptoms (SANS) scores; B: Correlation between serum brain-derived neurotrophic factor (BDNF), serotonin (5-HT), and dopamine (DA) levels and PANSS scores; C: Correlation between serum BDNF, 5-HT, and DA levels and SANS scores. PANSS: Positive and negative syndrome scale; SANS: Scale for the assessment of negative symptoms; BDNF: Brain-derived neurotrophic factor; 5-HT: Serotonin; DA: Dopamine.